• 基本信息
    导师姓名: 葛盛芳 学科代码: 100212
    性别: 学科名称: 眼科学
    培养单位: 附属第九人民医院 三级学科
    导师类型: 博士生导师 专业领域名称:
    联系方式: geshengfang@hotmail.com 021-53314247 专业领域代码:
    邮编: 200011 邮箱地址: geshengfang@hotmail.com
  • 研究方向 (点击浏览详细信息)
  • 社会任职
     
    中国生物物理学会 辐射与环境专业委员会常务委员
    上海市眼眶病眼肿瘤重点实验室副主任
    上海法院知识产权技术咨询专家
    曾兼任上海市生物化学与分子生物学学会理事。任<转化医学杂志>编委,《上海交通大学学报(医学版)》审稿人。
    教育部学位与研究生教育发展中心评审专家
  • 科研项目
    项目编号项目名称课题来源起止年月批准经费承担职责
    12275178药物清除放射诱导的衰老细胞提高葡萄膜黑色素瘤辐射效应的机制研究国家自然科学基金项目 2023-01~2026-12 56万元  课题负责人
    U1932135 富氧碳基纳米材料协同重离子放疗杀伤肿瘤的作用及机理研究国家自然科学基金项目 2020-01~2023-12 60万元  课题负责人
    81772875LncRNA L12–PTPRZ1通路在葡萄膜黑色素瘤靶向治疗中的作用机理研究国家自然科学基金项目 2018-01~2021-12 55万元  课题负责人
    U1432117lncRNA-29314916-CCNB2通路在重离子放疗中的辐射增敏机理研究国家自然科学基金项目 2015-01~2017-12 68万元  课题负责人
    201402014常见眼恶性肿瘤诊疗新技术、规范及其应用研究国家卫计委公益性行业科研专项项目 2014-06~2017-06 1262万元  课题参与人
    13JC1406202lncRNA-15:23930854通过调控有关蛋白参与低氧诱导的癌细胞恶性转化过程上海市基础研究重点 2013-09~2016-08 30万元  课题负责人
    XDA01040411肿瘤干细胞分离、鉴定及特异标记物的研究及基于肿瘤干细胞特征的靶向药物研究中国科学院战略性先导科技专项资助A类 2013-01~2017-12 200万元  课题参与人
    81172323导入PRC2基因修复肿瘤细胞IGF2遗传印迹丢失的作用及其机制研究国家自然科学基金项目 2012-01~2015-12 64万元  课题负责人
    10979034重离子协同腺病毒载体靶向杀灭肿瘤细胞的机理研究国家自然科学基金项目 2010-01~2012-12 54万元  课题负责人
    2010CB529902靶向基因治疗的应用基础研究973计划 2010-01~2014-12 144万元  课题参与人
    091024851基因-MicroRNA共表达新型腺病毒对荷瘤鼠肿瘤生长的影响第三期国家大学生创新性实验计划项目 2009-11~2011-06 3万元  课题负责人
    09ZZ110基因-小干扰RNA共表达肿瘤基因治疗新策略的研究上海市教委 2009-01~2011-12 15万元  课题负责人
    08ZR1412500基因-小干扰RNA共表达策略在肿瘤基因治疗中的应用研究上海市科委 2008-11~2010-12 10万元  课题负责人
    ZD0702Trail-siPROM1共表达双靶点胃肠肿瘤干细胞基因治疗新策略研究仁济医院合作研究项目 2007-10~2010-09 25万元  课题负责人
  • 学术论文
    作者论文标题期刊名出版年卷期页码
    Fu Y, Yu J, Li F,  Oncometabolites drive tumorigenesis by enhancing protein acylation: from chromosomal remodelling to nonhistone modification.  J Exp Clin Cancer Res(IF 12.658 )  2022  41(1):144 
    Yao Y, Gu X, Xu X,, Jia R  Novel insights into RB1 mutation  Cancer letters (IF 9.756)  2022  547:215870 
    Chai P, Jia R, Li Y, Zhou C, Gu X, Yang L, Shi H, Tian H, Lin H, Yu J, Zhuang A,, Jia R, Fan X.  Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma.  Prog Retin Eye Res(IF19.704)  2022  89:101030 
    Jia S, Zhu T, Shi H, Zong C, Bao Y, Wen X,, Ruan J, Xu S, Jia R, Fan X.  American Joint Committee on Cancer Tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma.  Ophthalmology(IF14.277)  2022  129(7):771-780. 
    Tian H, Shi H, Yu J,, Ruan J  Biophysics Role and Biomimetic Culture Systems of ECM Stiffness in Cancer EMT  Global challenges (IF 5.135)  2022  6(6):2100094 
    Huang Y, Zhang L, Ji Y, Deng H, Long M,, Su Y, Chan SY, Loh XJ, Zhuang A, Ruan J  A non-invasive smart scaffold for bone repair and monitoring.  Bioactive materials (IF 16.874)  2022  19:499-510 
    Yu J, Chai P, Xie M,, Ruan J, Fan X, Jia R  Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma.  Genome biology (IF 17.906)  2021  22(1):85 
    Lin H, Yu J, Gu X,, Fan X  Novel insights into exosomal circular RNAs: Redefining intercellular communication in cancer biology.  Clinical and translational medicine (IF 8.554)  2021  11(12):e636 
    Yang L, Gu X, Yu J,, Fan X.  Oncolytic Virotherapy: From Bench to Bedside  Frontiers in cell and developmental biology (IF 6.081)  2021  9:790150 
    Wang S, Chen B, Ouyang L, Wang D, Tan J, Qiao Y,, Ruan J, Zhuang A, Liu X, Jia R  A Novel Stimuli-Responsive Injectable Antibacterial Hydrogel to Achieve Synergetic Photothermal/Gene-Targeted Therapy towards Uveal Melanoma.  Advanced science (IF 17.521)  2021  8(18):e2004721 
    Chai P, Yu J, Wang X,, Jia R  BMP9 promotes cutaneous wound healing by activating Smad1/5 signaling pathways and cytoskeleton remodeling.  Clinical and translational medicine (IF 8.554)  2021  11(1):e271 
    Gu X, Xie M, Jia R,  Publication Trends of Research on Retinoblastoma During 2001-2021: A 20-Year Bibliometric Analysis.  Frontiers in medicine (IF 5.058)  2021  8:675703 
    Ding Y, Yu J, Chen X, Wang S, Tu Z, Shen G, Wang H, Jia R,, Ruan J, Leong KW, Fan X  Dose-Dependent Carbon-Dot-Induced ROS Promote Uveal Melanoma Cell Tumorigenicity via Activation of mTOR Signaling and Glutamine Metabolism.  Advanced science (IF17.521)  2021  8(8):2002404 
    Li P, He J, Yang Z,, Zhang H, Zhong Q, Fan X  ZNNT1 long noncoding RNA induces autophagy to inhibit tumorigenesis of uveal melanoma by regulating key autophagy gene expression.  Autophagy (IF 13.391)  2020  16(7), 1186–1199 
    Fan J, Xu Y, Wen X,, Jia R, Zhang H, Fan X  A Cohesin-Mediated Intrachromosomal Loop Drives Oncogenic ROR lncRNA to Accelerate Tumorigenesis.  Molecular therapy : the journal of the American Society of Gene Therapy (IF 12.910)  2020  27(12), 2182–2194 
    Wen X, Wang H, Chai P, Fan J, Zhang X, Ding T, Jia R,, Zhang H, Fan X  An Artificial CTCF Peptide Triggers Efficient Therapeutic Efficacy in Ocular Melanoma.  Molecular therapy oncolytics (IF 6.311)  2020  18:317-325 
    Liu T, Zhang H, Fang J, Yang Z, Chen R, Wang Y, Zhao X,, Yu J, Huang J  AGO2 phosphorylation by c-Src kinase promotes tumorigenesis.  Neoplasia (IF 6.218)  2020  22(3):129-141 
    Yu J, Loh XJ, Luo Y,, Fan X, Ruan J  Insights into the epigenetic effects of nanomaterials on cells.  Biomaterials science (IF 7.590)  2020  8(3), 763–775 
    Chai P, Yu J,, Jia R, Fan X  Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis.  Journal of hematology & oncology (IF 23.168)  2020  13(1):43 
    Wang H, Yang J, Pan H, Tai MC, Maher MH, Jia R,, Lu L  Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway.  OncoTargets and therapy (IF 4.345)  2020  13:3903-3920 
    Li F, Xu Y, Xu X,, Zhang F, Zhang H, Fan X  lncRNA HotairM1 Depletion Promotes Self-Renewal of Cancer Stem Cells through HOXA1-Nanog Regulation Loop.  Molecular therapy. Nucleic acids (IF 10.183)  2020  22:456-470 
    Gu X, Yu J, Chai P,, Fan X  Novel insights into extrachromosomal DNA: redefining the onco-drivers of tumor progression.  Journal of experimental & clinical cancer research : CR (IF 12.658)  2020  39(1):215 
    Ding X, Cao Y, Xing Y,, Lin M, Li J  TIMP-1 Mediates Inflammatory and Immune Response to IL-6 in Adult Orbital Xanthogranulomatous Disease.  Ocular immunology and inflammation (IF 3.728)  2020  28(2), 288–297 
    Chai P, Yu J,, Jia R*, Fan X*.   Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis.   J Hematol Oncol (IF 23.168)  2020  13(1):43 
    Xie M, Yu J,, Huang J, Fan X  SUMOylation homeostasis in tumorigenesis.  Cancer letters (IF 9.756)  2020  469:301-309 
    Ji Y, Zhou Y, Shen Q, Xu W,, Gu L, Fan X  Prediction of late displacement of the globe in orbital blowout fractures.  Acta ophthalmologica (IF 3.988)  2020  98(2), e197–e202 
    He X, Chai P, Li F, Zhang L, Zhou C, Yuan X, Li Y, Yang J, Luo Y,, Zhang H, Jia R, Fan X  A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3.  Molecular cancer (IF 41.444)  2020  19(1):115 
    Chai P, Yu J, Jia R, Wen X, Ding T, Zhang X, Ni H, Jia R,, Zhang H, Fan X  Generation of onco-enhancer enhances chromosomal remodeling and accelerates tumorigenesis.  Nucleic acids research (IF 19.160)  2020  48(21):12135-12150 
    Li Y, He J, Qiu C, Shang Q, Qian G, Fan X*,, Jia R*.   The oncolytic virus H101 combined with GNAQ siRNA-mediated knockdown reduces uveal melanoma cell viability.  J Cell Biochem. (IF 4.480)  2019  120(4):5766-5776. 
    Chen J, Li F, Xu Y, Zhang W, Hu Y, Fu Y, Xu W,, Fan X, Lu L  Cholesterol modification of SDF-1-specific siRNA enables therapeutic targeting of angiogenesis through Akt pathway inhibition.  Experimental eye research (IF 3.770)  2019  184:64-71 
    Ding Y, Yang J, Ma Y, Yao T, Chen X,, Wang L, Fan X  MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2.  Journal of experimental & clinical cancer research : CR (IF 12.658)  2019  38(1), 498 
    Jia R, Chai P, Wang S, Sun B, Xu Y, Yang Y,, Jia R, Yang YG, Fan X  m6A modification suppresses ocular melanoma through modulating HINT2 mRNA translation.  Molecular cancer (IF 41.444)  2019  18(1), 161 
    Shang Q, Li Y, Wang H,, Jia R.   Altered expression profile of circular RNAs in conjunctival melanoma.  Epigenomics. (4.357)  2019  11(7):787-804. 
    Zhao H, Pan H, Wang H, Chai P,, Jia R, Fan X.   SKP2 targeted inhibition suppresses human uveal melanoma progression by blocking ubiquitylation of p27.   Onco Targets Ther. (IF 4.345)  2019  12:4297-4308 
    Shang Q, Yang Z, Jia R,  The novel roles of circRNAs in human cancer.  Mol Cancer (IF 41.444)  2019  18(1):6 
    Yang Z, Gu Q, Wang Y, Liu B, Zhou G, Shao C, Ruan J, Jia R,  Heavy-Ion Carbon Radiation Regulates Long Non-Coding RNAs in Cervical Cancer HeLa Cells.  Journal of Cancer (IF 4.478)  2019  10(21), 5022–5030 
    Chai P, Jia R, Jia R, Pan H, Wang S, Ni H, Wang H, Zhou C, Shi Y,, Zhang H, Fan X.  Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis.  Nucleic Acids Res(IF 19.160)  2018  46(12):6041-6056 
    Li Y, Shang Q, Li P, Cao J, Zhu L, Jager MJ, Fan X,, Jia R  Characterization of a conjunctival melanoma cell line CM-AS16, newly-established from a metastatic Han Chinese patient.  Exp Eye Res (IF 3.770)  2018  173:51-63 
    Ruan J, Wang Y, Li F, Jia R, Zhou G, Shao C, Zhu L, Cui M, Yang DP,  Graphene Quantum Dots for Radiotherapy.  ACS Appl Mater Interfaces.(IF10.383)  2018  10(17):14342-14355 
    Li P, Li Y, Zhu L, Yang Z, He J, Wang L, Shang Q, Pan H, Wang H, Ma X, Li B, Fan X,, Jia R*, Zhang H*.  Targeting secreted cytokine BMP9 gates the attenuation of hepatic fibrosis.  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (IF 6.633)  2017  864(3):709-720 
    Li G, Wang L, Jiang Y, Kong X, Fan Q,, Hao Y.  Upregulation of Akt signaling enhances femoral fracture healing by accelerating atrophic quadriceps recovery.  Biochim Biophys Acta  2017  1863(11):2848-2861 
    Li Y, Jia R,  Role of Epigenetics in Uveal Melanoma.  Int J Mol Med (IF 5.314)  2017  40(4):979-986 
    Bi J, Li P, Li C, He J, Wang Y, Zhang H, Fan X, Jia R,  The SDF-1/CXCR4 chemokine axis in uveal melanoma cell proliferation and migration  Tumour Biol  2016  37(3):4175-82 
    Zhang L, Jia R, Zhao J, Fan J, Zhou Y, Han B, Song X, Wu L, Zhang H, Song H,, Fan X*  Novel mutations in the RB1 gene from Chinese families with a history of retinoblastoma  Tumour Biol.  2015  36(4):2409-20 
    Pan H, Jia R, Zhang L, Xu S, Wu Q, Song X, Zhang H,, Xu XL*, Fan X*  BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells.  Int J Biochem Cell Biol (5.652)  2015  60(3):176-84 
    Fan J, Xing Y, Wen X, Jia R, Ni H, He J, Ding X, Pan H, Qian G,, Hoffman AR, Zhang H, Fan X  Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis  Genome Biol (IF 17.906)  2015  16(1):139-156 
    Bi J,  Potential roles of BMP9 in liver fibrosis  Int J Mol Sci (IF 6.208)  2014  15(11):20656-67 
    Zhang H, Zeitz MJ, Wang H, Niu B,, Li W, Cui J, Wang G, Qian G, Higgins MJ, Fan X, Hoffman AR, Hu JF.   Long noncoding RNA-mediated intrachromosomal interactions promote imprinting at the Kcnq1 locus  J Cell Biol (IF8.077)  2014  204(1):61-75 
    Jia R, Xu S, Huang X, Song X, Pan H, Zhang L, He F, Lin M,, Fan X*.  Pingyangmycin as First-Line Treatment for Low-Flow Orbital or Periorbital Venous Malformations: Evaluation of 33 Consecutive Patients  JAMA Ophthalmol (IF 8.253)  2014  132(8):942-8 
    Wang J, Jia R, Zhang Y, Xu X, Song X, Zhou Y, Zhang H,, Fan X*.  The role of Bax and Bcl-2 in gemcitabine-mediated cytotoxicity in uveal melanoma cells  Tumour Biol  2014  35(2):1169-75 
    Ye L, Zhao X, Lu J, Qian G, Zheng JC,  Knockdown of TIGAR by RNA interference induces apoptosis and autophagy in HepG2 hepatocellular carcinoma cells.  Biochem Biophys Res Commun (IF 3.322)  2013  436(9):1-6 
    Zhang H, Jiao W, Sun L, Fan J, Chen M, Wang H, Xu X, Shen A, Li T, Niu B,, Li W, Cui J, Wang G, Sun J, Fan X, Hu X, Mrsny RJ, Hoffman AR, Hu JF  Intrachromosomal Looping Is Required for Activation of Endogenous Pluripotency Genes during Reprogramming  Cell Stem Cell (IF25.269)  2013  13(1):30-5 
    Cun B, Song X, Jia R, Wang H, Zhao X, Liu B,, Fan X  Cell growth inhibition in HPV 18 positive uveal melanoma cells by E6/E7 siRNA  Tumour Biol  2013  34(3):1801-6 
    Zhang Y, Jia R, Wang J, Xu X, Yao Y,, Fan X*  Targeted Silencing of MART-1 Gene Expression by RNA Interference Enhances the Migration Ability of Uveal Melanoma Cells  Int. J. Mol. Sci (IF 6.208)  2013  14(4):15092-15104 
    Li C, Chen P, Zhang J, Zhang L, Huang X, Yao Y, Che X, Fan X,, Wang Z.  Enzyme-induced vitreolysis can alleviate the progression of diabetic retinopathy through the HIF-1α pathway.  Invest Ophthalmol Vis Sci (IF 4.925)  2013  54(12):1-12 
    Li C, Wu Q, Liu B, Yao Y, Chen Y, Zhang H, Wang C, Cao J,  Detection and Validation of Circulating Endothelial Cells, a Blood-based Diagnostic Marker of Acute Myocardial Infarction  PLoS ONE (IF 3.752)  2013  8(3):58478-0 
    Zhang J, Sun Q, Zhang Z,, Han ZG, Chen WT  Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop  Oncogene (IF 8.756)  2012  32(1):61-69 
    Hao Y, Ma Y, Wang X, Jin F,  Short-term muscle atrophy caused by botulinum toxin-A local injection impairs fracture healing in the rat femur.  J Orthop Res (IF 3.102)  2012  30(4):574-80 
    Xin Song, Haibo Wang, Renbing Jia, Biyun Cun, Xiaoping Zhao, Yixiong Zhou, Xiaofang Xu, Guanxiang Qian,  Combined treatment with an oncolytic adenovirus and vincristine antitumor activity against retinoblastoma cells  Int. J. Mol. Sci. (IF 6.208)  2012  13(0):10736-10749 
    Wang H, Song X, Zhang H, Zhang J, Shen X, Zhou Y, Fan X, Dai L, Qian G, Hoffman AR, Hu JF,  Potentiation of tumor radiotherapy by a radiation-inducible oncolytic and oncoapoptotic adenovirus in cervical cancer xenografts  Int J Cancer(IF 7.316)  2012  15;130 (2):443-53 
    Sun J, Zhou J, Zhao P, Lian J, Zhu H, Zhou Y, Sun Y, Wang Y, Zhao L, Wei Y, Wang L, Cun B, Ge S,  High Prevalence of Myopia and High Myopia in 5060 Chinese University Students in Shanghai  Invest Ophthalmol Vis Sci. (IF 4.925)  2012  53(12):7504-9 
    Huang X, Jia R, Zhao X, Liu B, Wang H, Wang J, Zhou Y, Cun B,, Fan X.  Recombinant oncolytic adenovirus H101 combined with siBCL2: cytotoxic effect on uveal melanoma cell lines  Br J Ophthalmol (IF 5.908)  2012  96(10):1331-8 
    Wang Z, Jia R,, He T, Zhang Y, Yang Y, Wang Y, Shi W, Ji Y, Ye F, Chen P, Lu J, Sun J, Xu X, Zhou Y, Gu P, Luo M, Lu H, Fan X  Ocular Complications of Human Immunodeficiency Virus Infection in Eastern China  Am J Ophthalmol (IF 5.488)  2012  153(2):363-369 
    Cun B, Song X, Jia R, Zhao X, Wang H,, Fan X  Combination of oncolytic adenovirus and dacarbazine enhances antitumor ability against uveal melanoma cells via cell cycle block   Cancer Biology & Therapy (IF 4.875)  2012  13(2):77-84 
    Guo H, Hu X,, Qian G, Zhang J  Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation  Int J Biochem Cell Biol (IF 5.652)  2012  44(9):1465-72 
    Huang X, Wang L, Zhang H, Wang H, Zhao X, Qian G, Hu J,, Fan X  Therapeutic efficacy by targeting correction of notch1-induced aberrants in uveal tumors  PLoS ONE (IF 3.752)  2012  7(8):44301-0 
    Yao Y, Wang L, Zhang H, Wang H, Zhao X, Zhang Y, Zhang L, Fan X, Qian G, Hu J,  A Novel Anticancer Therapy That Simultaneously Targets Aberrant p53 and Notch Activities in Tumors  PLoS ONE (IF 3.752)  2012  7(10):46627-0 
    Fan J, Zhou Y, Huang X, Zhang L, Yao Y, Song X, Chen J, Hu J,, Song H, Fan X.  The combination of polyalanine expansion mutation and a novel missense substitution in transcription factor FOXL2 leads to different ovarian phenotypes in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) patients.  Hum Reprod (IF 6.353)  2012  27(11):3347-57 
    Zhang H, Niu B, Hu JF,, Wang H, Li T, Ling J, Steelman BN, Qian G, Hoffman AR.  Interruption of intrachromosomal looping by CTCF decoy proteins abrogates genomic imprinting of human insulin-like growth factor II  Journal of Cell biology (IF 8.077)  2011  193(3):475-87 
    Zhang J, Guo H, Zhang H, Wang H, Qian G, Fan X, Hoffman AR, Hu JF,  Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1.  Cancer (IF 6.921)  2011  117(1):86-95 
    Xu H, Ni P, Chen C, Yao Y, Zhao X, Qian G, Fan X,  SP1 suppresses phorbol 12-myristate 13-acetate induced up-regulation of human regucalcin expression in liver cancer cells.  Mol Cell Biochem (IF 3.842)  2011  355(1):9-15 
    Song X, Zhou Y, Jia R, Xu X, Wang H, Hu J,, Fan X  Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101.   Investigative Ophthalmology and Vision Science(IF 4.925)  2010  51(5):2626-35 
    Zhang P, Ying L, Xu R,, Mei W, Li F, Dai B, Lu J, Qian G  Tumor-Specific, Hypoxia-Regulated WWOX Expression Adenovirus Inhibits Human Non-Small Cell Lung Cancer Growth in Vivo.   Human Gene Therapy (IF 4.793)  2010  21(1):27-39 
    Zhang J, Huang S, Zhang H, Wang H, Guo H, Qian G, Fan X, Lu J, Hoffman AR, Hu JF,  Targeted knockdown of Bcl2 in tumor cells using a synthetic TRAIL 3’-UTR microRNA.  Int J Cancer (IF 7.316)  2010  126(9):2229-2239 
    Zhang J, Guo H, Qian G,, Ji H, Hu X, Chen W.   MiR-145, a new regulator of the DNA Fragmentation Factor-45 (DFF45)-mediated apoptotic network  Mol Cancer(IF 41.444)  2010  9(1):211-220 
    Zhou Y, Song X, Jia R, Wang H, Dai L, Xu X, Gu P,, Fan X  Radiation-inducible human tumor necrosis factor-related apoptosis inducing ligand (TRAIL) gene therapy:a novel treatment for radioresistant uveal melanoma.  Pigment Cell & Melanoma Research(IF 4.159)  2010  23:661-674 
    Zhang H, Wang H, Zhang J, Qian G, Niu B, Fan X, Lu J, Hoffman AR, Hu JF,  Enhanced Therapeutic Efficacy by Simultaneously Targeting Two Genetic Defects in Tumors.  Mol Ther(IF 12.910)  2009  17 (1):57-64 
    Zhang X, Mei W, Zhang L, Yu H, Zhao X, Fan X, Qian G,  Co-expression of P1A35-43/β2m fusion protein and co-stimulatory molecule CD80 elicits effective anti-tumor immunity in the P815 mouse mastocytoma tumor model.  Oncol Rep. (IF 4.136)  2009  22(5):1213-1220 
    Fang L, Wang K, Liu X, Zhang L, Zhang X, Qian L, Lu J, Qian G,  A Study on the Anti-Tumor Immunity Induced by Gene-Modified Melanoma B16 Cells.   Oncol Rep. (IF 4.136)  2008  19(6):1589-95 
    Zhao X, Wang L, Sun Y, Ye L, Lu J, Yuan Y, Qian G,  The endoplasmic reticulum (ER)-target protein Bik induces Hep3B cells apoptosis by the depletion of the ER Ca(2+) stores.  Mol Cell Biochem. (IF 3.842)  2008  312(1-2):33-8 
    Zhao X, Sun Y, Yu H, Ye L, Zhang L, Lu J, Yuan Y, Qian G,  Apoptosis induced by BIK was decreased with RNA interference of caspase-12.   Biochem Biophys Res Commun. (IF 3.322)  2007  359(4):896-901. 
    X. Liu, L. Zhang, X. Zhang, H. Yu, X. Zhao, J. Lu, G. Qian ,  The effect of co-expression costimulatory molecule CD80 on uptake of antigen peptide-MHC class I-GFP complex by specific T cells.   Int J Oncol. (IF 5.884)  2007  30(6):1389-1396 
    Yu H, Zhao X, Huang S, Lu J, Qian G,  Blocking Notch1 Signaling by RNA Interference can Induce Growth Inhibition in Hela Cells.  Int J Gynecol Cancer. (IF 4.661)  2007  17(2):511-6. 
    Jia RB, Zhang P, Zhou YX, Song X, Liu HY, Wang LZ, Luo M, Lu J,, Fan XQ.   VEGF-Targeted RNA Interference Suppresses Angiogenesis and Tumor Growth of Retinoblastoma.  Ophthalmic Res. (IF 3.031)  2007  39(2):108-115.